Pfizer cuts 6,000 manufacturing jobs; Finland targets illegal imports in online sting;

> Streamlining the combined Wyeth-Pfizer operations--and such accompanying cost cuts as those to be realized by the just announced facility closings and elimination of 6,000 jobs--is a key reason the two companies merged. Item

> Finnish customs officials are investigating illegal drug imports, zeroing in on 800 online orders of medication from abroad placed over a two-month period. Article

> Two non-sterile lots of metronidazole injection, manufactured by Claris Lifesciences and distributed by Sagent, have prompted a nationwide recall. Item

> Medical and surgical equipment distributor Owens & Minor has expanded its scope with the launch of OM HealthCare Logistics, a Louisville, KY-based cGMP-compliant third-party logistics provider offering cold chain management, reverse logistics, repackaging, sample management and kitting. Announcement

> A pharmaceutical manufacturing plant is among the first the U.S. to achieve a newly developed EPA designation for pharmaceutical manufacturing as well as an environmental leadership award. Release

Suggested Articles

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.

India’s Aurobindo, which has yet to close its $1 billion deal to buy 300 Sandoz products in the U.S., continues to rack up FDA issues.